GREEN CROSS

About us
- Our Culture
  
  Mission & Vision
  
  Core Value
  
  Responsibility
- Our People
  
  Leaders
  
  Board of Directors

R&D

Immunization against tetanus and 
diphtheria is required by law under the 
National Immunization Program in S.Korea.

Products
- I.V.-Globulin SN inj.
  Human normal immunoglobulin G & Colorless transparent liquid formulation
- Albumin inj.-GCC
  Human albumin solution & Yellow to yellowish transparent liquid formulation
- GC FLU pre-filled syringe inj.
  Prefilled syringe injections & Influenza vaccine (split virion, inactivated)
- GreenGene F inj.
  Blood coagulation factor VIII, recombinant & White or light yellow powder, odorless, colorless and transparent vials
- Products
  
  Plasma Derivatives
  
  Vaccines
  
  Prescription Drugs
  
  Over-the-counter Drugs
- Product Search
Investors
Green Cross

199,500 KRW

-3,000 -1.48%

Green Cross Holdings

37,850 KRW

-400 -1.05%
- Financial Highlights
- Detailed Share Price
  
  Real-time Quotes
  
  Financial Index
  
  Daily Quotes
- Quarterly Results
  
  Financial Statements
  
  Shareholders
  
  Dividend Information
- Presentations

Search

Keyword Search: Plasma Derivatives Office Vaccines Subsidiary Pipeline R&D Media Stock Company Recruit

Product Search

About us
R&D
Products
- Products
Investors
Newsroom
- Press Release
Careers
Contact us
- Inquiry

KOR

CHALLENGE
INNOVATION
DISCOVERY

```
Ensuring people’s health
```

Advanced capabilities in 
new drug development

```
The key to
creating new drugs
```

What we are working on

R&DR&D Story

We specialize in the development of essential
but difficult-to-make drugs.

R&D Pipeline

We strive to develop new
and innovative products.

R&DPartnership

To strengthen our pipeline and
our understanding of disease.

PRODUCTS I.V.-Globulin SN i...

I.V.-Globulin SN inj.

Including high purity IgG 
immune function improved
formulation

VIEW MORE

PRODUCTS Albumin inj.-GCC

Albumin inj.-GCC

Yellow to yellowish transparent 
liquid formulation
& Human albumin solution

VIEW MORE

PRODUCTS Green-VIII inj
```
Human coagulation factor VIII
```
VIEW MORE

Who we are?

Stock Info

Share price
at 3:49 PM, UTC

Our business

NO.1

in plasma & flu vaccine
market (S.Korea)

50

We are exporting our 
products to more than 
50 countries

TOP
```
Vaccine producer of 
PAHO market
```

About Us: We possess 17 pharmaceutical and
healthcare affiliated companies. VIEW MORE

What's happening

Newsroom

Newsroom

Green Cross Receives WHO Prequalification for GCFlu Quadrivalent

4 Sep, 2013

R&D
BUSINESS
MEDIA